Characterization of the 7q2l-q22 amplicon identifies ARPCIA, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer

Genes Chromosomes and Cancer

Volumn 48, Issue 4, 2009, Pages 330-339

  Laurila, Eeva ^a   Savinainen, Kimmo ^a   Kuuselo, Riina ^a   Karhu, Ritva ^a   Kallioniemi, Anne ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; PROTEIN SUBUNIT; RNA; ARPC1A PROTEIN, HUMAN; DNA; SMALL INTERFERING RNA;

ACTIN POLYMERIZATION; AMPLICON; ARPC1A GENE; ARTICLE; CANCER CELL; CANCER INVASION; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE SILENCING; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; CELL MOTION; CHROMOSOME 7; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NONPARAMETRIC TEST; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ACTIN-RELATED PROTEIN 2-3 COMPLEX; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 7; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 62149123724     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20643     Document Type: Article

References (40)

1. Aguirre AJ, Brennan C, Bailey G, Sinha R, Feng B, Leo C, Zhang Y, Zhang J, Gans JD, Bardeesy N, Cauwels C, Cordon-Cardo C, Redston MS, DePinho RA, Chin L. 2004. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA 101:9067-9072.
2. Alarmo EL, Rauta J, Kauraniemi P, Karhu R, Kuukasjarvi T, Kal- lioniemi A. 2006. Bone morphogenetic protein 7 is widely over- expressed in primary breast cancer. Genes Chromosomes Cancer 45:411-419.
3. Albertson DG. 2006. Gene amplification in cancer. Trends Genet 22:447-455.
4. Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J, Adany R. 2001. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytome- try 46:222-232.
5. Bardeesy N, DePinho RA. 2002. Pancreatic cancer biology and genetics. Nat Rev Cancer 2:897-909.
6. Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, Kallioniemi A. 2000. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 92:1252-1259.
7. Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, Tibshirani R, Maitra A, Pollack JR. 2005. Array- based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7:556-562.
8. Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Bren- ton JD, Edwards PA, Caldas C. 2005. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 24:5235-5245.
9. Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C, Lasorsa L, Letessier A, Ginestier C, Monville F, Esteyries S, Adelaide J, Esterni B, Henry C, Ethier SP, Bibeau F, Mozziconacci MJ, Charafe-Jauffret E, Jacquemier J, Bertucci F, Birnbaum D, Theillet C, Chaffanet M. 2005. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res 3:655-667.
10. Gluz O, Wild P, Meiler R, Diallo-Danebrock R, Ting E, Mohr- mann S, Schuett G, Dahl E, Fuchs T, Herr A, Gaumann A, Frick M, Poremba C, Nitz UA, Hartmann A. 2008. Nuclear kar- yopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity. Int J Cancer 123:1433-1438.
11. Goley ED, Welch MD. 2006. The ARP2/3 complex: An actin nucleator comes of age. Nat Rev Mol Cell Biol 7:713-726.
12. Gournier H, Goley ED, Niederstrasser H, Trinh T, Welch MD. 2001. Reconstitution of human Arp2/3 complex reveals critical roles of individual subunits in complex structure and activity. Mol Cell 8:1041-1052.
13. Gysin S, Rickert P, Kastury K, McMahon M. 2005. Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines. Genes Chromosomes Cancer 44:37-51.
14. Heidenblad M, Schoenmakers EF, Jonson T, Gorunova L, Velt- man JA, van Kessel AG, Hoglund M. 2004. Genome-wide array- based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. Cancer Res 64:3052-3059.
15. Holzmann K, Kohlhammer H, Schwaenen C, Wessendorf S, Kes- tler HA, Schwoerer A, Rau B, Radlwimmer B, Dohner H, Lichter P, Gress T, Bentz M. 2004. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 64:4428-4433.
16. Huang X, Godfrey TE, Gooding WE, McCarty KS, Jr, Gollin SM. 2006. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45:1058-1069.
17. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
18. Kaneda A, Kaminishi M, Sugimura T, Ushijima T. 2004. Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett 212:203-210.
19. Karhu R, Mahlamaki E, Kallioniemi A. 2006. Pancreatic adenocar- cinoma-Genetic portrait from chromosomes to microarrays. Genes Chromosomes Cancer 45:721-730.
20. Kau TR, Way JC, Silver PA. 2004. Nuclear transport and cancer: From mechanism to intervention. Nat Rev Cancer 4:106-117.
21. Kauraniemi P, Kuukasjarvi T, Sauter G, Kallioniemi A. 2003. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer. Am J Pathol 163:1979-1984.
22. Klimstra DS, Longnecker DS. 1994. K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 145:1547-1550.
23. Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuz- men S, Mousses S, Kallioniemi A. 2007. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Res 67:1943-1949.
24. Lockwood WW, Chari R, Coe BP, Girard L, Macaulay C, Lam S, Gazdar AF, Minna JD, Lam WL. 2008. DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers. Oncogene 27:4615-4624.
25. Loukopoulos P, Shibata T, Katoh H, Kokubu A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, Ohki M, Inazawa J, Hirohashi S. 2007. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocar- cinoma: Identification of genetic indicators that predict patient outcome. Cancer Sci 98:392-400.
26. Mahlamaki EH, Kauraniemi P, Monni O, Wolf M, Hautaniemi S, Kallioniemi A. 2004. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer. Neoplasia 6:432-439.
27. Morohara K, Nakao K, Tajima Y, Nishino N, Yamazaki K, Kaetsu T, Suzuki S, Tsunoda A, Kawamura M, Aida T, Tachi- kawa T, Kusano M. 2005. Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology. Cancer Genet Cytogenet 161:57-62.
28. Otsubo T, Iwaya K, Mukai Y, Mizokami Y, Serizawa H, Matsuoka T, Mukai K. 2004. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod Pathol 17:461-467.
29. Parssinen J, Kuukasjarvi T, Karhu R, Kallioniemi A. 2007. High- level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer. Br J Cancer 96:1258-1264.
30. Rauta J, Alarmo EL, Kauraniemi P, Karhu R, Kuukasjarvi T, Kal- lioniemi A. 2006. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res Treat 95:257263.
31. Riegman PH, Vissers KJ, Alers JC, Geelen E, Hop WC, Tilanus HW, van Dekken H. 2001. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res 61:31643170.
32. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE. 1997. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57:1731-1734.
33. Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, Kato H, Matsuoka T, Mukai K. 2006. Coexpression of actin- related protein 2 and Wiskott-Aldrich syndrome family verpro- line-homologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res 12:2449-2454.
34. Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K, Hirohashi S, Inazawa J, Imoto I. 2008. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization. Cancer Sci 99:986-994.
35. Sy SM, Wong N, Lai PB, To KF, Johnson PJ. 2005. Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma. Mod Pathol 18:686-692.
36. Vadlamudi RK, Li F, Barnes CJ, Bagheri-Yarmand R, Kumar R. 2004. p41-Arc subunit of human Arp2/3 complex is a p21- activated kinase-1-interacting substrate. EMBO Rep 5:154160.
37. Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS. 2005. Tumor cells caught in the act of invading: Their strategy for enhanced cell motility. Trends Cell Biol 15:138145.
38. Welch MD, DePace AH, Verma S, Iwamatsu A, Mitchison TJ. 1997. The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin ilament assembly. J Cell Biol 138:375-384.
39. Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP. 2006. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res 66:11632-11643.
40. Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F. 2004. siRNA Selection Server: An automated siRNA oligonucleotide prediction server. Nucleic Acids Res 32:W130-W134.